Elisabeth Bjork - 20 May 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Reporting relationship: Director
Issuer ticker: PHVS
Reported as of: 20 May 2026
Net transaction value: -$293,166
SEC form: 4
Accepted by SEC: 22 May 2026, 14:54:12 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Marnus Nel, Attorney-in-Fact for Elisabeth Bjork

Key filing fact

Elisabeth Bjork filed Form 4 for Pharvaris N.V. (PHVS) on 22 May 2026.

Key facts

This page summarizes Elisabeth Bjork's Form 4 filing for Pharvaris N.V. (PHVS).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 May 2026, 14:54.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$293,166.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001810406 Primary reporting owner

Bjork Elisabeth

Relationship: Director
Address: 1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature: /s/ Marnus Nel, Attorney-in-Fact for Elisabeth Bjork
Signature date: 22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares: +10,000
Change %: +66%
Price: $8.05^*
Shares after: 25,167
Date: 20 May 2026
Ownership: Direct
Footnotes: F1

PHVS transaction

Common Stock

Sale

Transaction value: $293,166
Shares: -10,000
Change %: -40%
Price: $29.32
Shares after: 15,167
Date: 20 May 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -10,000
Change %: -48%
Price: $0.000000^*
Shares after: 11,000
Date: 20 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,000
Exercise price: $8.05
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

This is a scheduled exercise and sale from 10b5-1 trading plan.

Footnote F2

The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $29.03 to $29.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.